
Rungesic P 50mg/325mg Tablet
Marketer
Indoscot Healthcare LLP
Salt Composition
Diclofenac (50mg) + Paracetamol (325mg)
Overview Rungesic P 50mg/325mg Tablet
Anagesic RP 50mg/325mg tablets offer pain relief and inflammation reduction. Indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, it also addresses muscle, back, tooth, ear, and throat pain. For optimal absorption and to minimize gastrointestinal upset, consume Anagesic RP with food, following your doctor's prescribed dosage and duration precisely. Common side effects can include nausea, vomiting, abdominal discomfort, appetite loss, dyspepsia, and diarrhea. Persistent or bothersome side effects warrant immediate medical attention; your physician can advise on mitigating strategies. Prior to use, individuals with pre-existing cardiac, renal, hepatic, or peptic ulcer conditions should consult their doctor, as should those on other medications. Pregnant or breastfeeding women must obtain medical clearance before commencing treatment.
Uses of Rungesic P 50mg/325mg Tablet
Analgesia
Major Benefits of Rungesic P 50mg/325mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Rungesic P 50mg/325mg tablets with a meal.
Common Side effects of Rungesic P 50mg/325mg Tablet:
- Nausea
- Vomiting
- Stomach pain/epigastric pain
- Heartburn
- Diarrhea
- Loss of appetite
How to use Rungesic P 50mg/325mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rungesic P 50mg/325mg tablet whole; do not chew, crush, or divide it. It should be administered with food.
How Rungesic P 50mg/325mg Tablet works:
Combiflam, a 50mg/325mg tablet, merges Diclofenac and Paracetamol to alleviate pain, fever, and inflammation. Its dual action inhibits the chemical signals triggering these symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Rungesic P 50mg/325mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Rungesic P 50mg/325mg tablets is contraindicated during pregnancy due to confirmed risks to the fetus. A physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the hazards. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Rungesic P 50mg/325mg tablets without significant concern. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Rungesic P 50mg/325mg Tablets, such as headaches, blurred vision, dizziness, or drowsiness, which may occur in some individuals.
KidneyCAUTION
Patients with kidney impairment should use Rungesic P 50mg/325mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Rungesic P 50mg/325mg tablets, potentially requiring dosage modification. Physician consultation is advised. Rungesic P 50mg/325mg tablets are contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Rungesic P 50mg/325mg Tablet :
Should you forget to take a Rungesic P 50mg/325mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rungesic P 50mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
